RPRX logo

Royalty Pharma (RPRX) Company Overview

Profile

Full Name:

Royalty Pharma plc

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

June 16, 2020

Indexes:

Not included

Description:

Royalty Pharma (RPRX) is a company that invests in pharmaceutical royalties. It buys rights to future sales of drugs from developers, allowing them to receive upfront cash. In return, Royalty Pharma earns money as the drugs generate sales, helping to fund new treatments and innovations in healthcare.

Key Details

Price

$33.42

Annual Revenue

$2.26 B(-3.86% YoY)

Annual EPS

$1.91(-24.51% YoY)

Beta

-0.02

Events Calendar

Earnings

Next earnings date:

May 9, 2025

Recent quarterly earnings:

Feb 11, 2025

Recent annual earnings:

Feb 11, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Feb 21, 2025
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Oct 25, 24 Citigroup
Buy
Aug 14, 24 Goldman Sachs
Buy
Jul 11, 24 Morgan Stanley
Overweight
Jun 3, 24 UBS
Neutral
Apr 12, 24 B of A Securities
Buy
Feb 20, 24 JP Morgan
Overweight
Feb 20, 24 Goldman Sachs
Buy
Nov 9, 23 Morgan Stanley
Overweight
Oct 11, 23 Morgan Stanley
Overweight
Aug 9, 23 Morgan Stanley
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Dividend per share

Dividend yield

Other

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Royalty Pharma?
  • Does Royalty Pharma pay dividends?
  • What sector is Royalty Pharma in?
  • What industry is Royalty Pharma in?
  • What country is Royalty Pharma based in?
  • When did Royalty Pharma go public?
  • Is Royalty Pharma in the S&P 500?
  • Is Royalty Pharma in the NASDAQ 100?
  • Is Royalty Pharma in the Dow Jones?
  • When was Royalty Pharma's last earnings report?
  • When does Royalty Pharma report earnings?
  • Should I buy Royalty Pharma stock now?

What is the ticker symbol for Royalty Pharma?

The ticker symbol for Royalty Pharma is NASDAQ:RPRX

Does Royalty Pharma pay dividends?

Yes, Royalty Pharma pays dividends. The last payment was $0.22, with an ex-dividend date on February 21, 2025

What sector is Royalty Pharma in?

Royalty Pharma is in the Healthcare sector

What industry is Royalty Pharma in?

Royalty Pharma is in the Biotechnology industry

What country is Royalty Pharma based in?

Royalty Pharma is headquartered in United States

When did Royalty Pharma go public?

Royalty Pharma's initial public offering (IPO) was on June 16, 2020

Is Royalty Pharma in the S&P 500?

No, Royalty Pharma is not included in the S&P 500 index

Is Royalty Pharma in the NASDAQ 100?

No, Royalty Pharma is not included in the NASDAQ 100 index

Is Royalty Pharma in the Dow Jones?

No, Royalty Pharma is not included in the Dow Jones index

When was Royalty Pharma's last earnings report?

Royalty Pharma's most recent earnings report was on Feb 11, 2025

When does Royalty Pharma report earnings?

The next expected earnings date for Royalty Pharma is May 9, 2025

Should I buy Royalty Pharma stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions